Study Puts Sensitive Diagnosis at the Heart of the Fight Against Malaria

What if one of the most powerful weapons against malaria is not a new drug or another mosquito net, but simply getting the point-of-care diagnosis right? A new study by Strathmore University researchers suggests that even small improvements in sensitivity of malaria testing could prevent deaths, reduce transmission and make scarce health resources work more efficiently.

A patient walks into a health facility with malaria, takes a rapid diagnostic test, and is told the result is negative. They leave without antimalarial treatment. But the test was not sensitive enough to detect malaria germs in the blood. Thus, it gave a false negative result.

The consequences of that missed diagnosis can extend well beyond the patient. The infection may progress to severe malaria or remain at low levels in the bloodstream, where it can persist unnoticed and continue the cycle of transmission when mosquitoes bite. It is this largely invisible gap in the fight against malaria that the study argues deserves far greater attention.

Published in the 3^rd August 2026 edition of Elsevier’s Epidemics journal, the mathematical modelling study found that improving malaria diagnostic sensitivity from 95 per cent to 98 per cent reduced false-negative cases by 60 per cent and malaria mortality by 14 per cent.

The study, “Optimizing malaria diagnostic sensitivity as a prerequisite for targeted vector control and rational antimalarial deployment: A compartmental modeling analysis,” was conceived and designed by Dr. Andrew Cole, Prof. John Odhiambo and Prof. Gilbert Kokwaro from Strathmore University.

The researchers, affiliated with the Strathmore Institute of Mathematical Sciences, the Centre for Climate Change and Health, Institut de gestion des soins de santé, and the SAIRC Research Network, seek to answer the following broad question: what happens when a health system becomes better at finding the infections it is currently missing?

The danger of a false  negative result  in malaria diagnosis

Malaria diagnosis is a critical gateway to treatment. Across much of sub-Saharan Africa, patients suspected of having malaria are generally tested using rapid diagnostic tests or microscopy before antimalarial treatment is initiated.

But diagnostic tests are not infallible. Field sensitivity can vary considerably depending on parasite density, test quality, storage conditions, operator training and other multivariate factors. The study notes that false-negative results have also been associated with genetic changes in malaria parasites affecting the proteins targeted by some commonly used rapid diagnostic tests.

For the researchers, that creates two problems. Some symptomatic patients who receive false-negative results remain untreated and risk progressing to severe disease. Others carry low-density infections that may persist for months without any clinical symptoms in the patient, quietly maintaining malaria transmission within communities.

The  mathematical model  used by the researchers considers a false-negative population in which about 85 per cent are asymptomatic submicroscopic infections. Although these infections may carry lower parasite densities, their prolonged duration allows for a conducive environment for parasite growth and means they can more efficiently maintain malaria presence  in a population despite elimination efforts.

The implication is significant: a malaria case missed by the health system may remain part of the transmission chain.

A small improvement, a large difference

To examine the problem, the researchers developed an eight-compartment mathematical model tracking malaria through infection, diagnosis, treatment, severe disease and recovery.

One feature distinguishes the model from many earlier approaches. Instead of treating diagnostic sensitivity as a fixed background assumption, the researchers made it a variable that could alter what happened to patients after they sought care.

Patients correctly diagnosed entered the treatment pathway. Those incorrectly diagnosed entered a false-negative pathway without antimalarial treatment. The difference between the two pathways was substantial. In the model, untreated symptomatic false-negative cases progressed towards severe disease at four times the rate assigned to correctly diagnosed and treated cases.

Moving diagnostic sensitivity from 95 to 98 per cent represents an improvement of only three percentage points. Yet because the proportion being missed falls from five per cent to two per cent, the false-negative burden drops by 60 per cent. The model associated that improvement with a 14 per cent reduction in mortality.

Should more resources for malaria be devoted to diagnosis?

The researchers then pushed the question further. They compared seven simulated intervention strategies allocating resources differently among vector control, diagnostic improvement and treatment.

The three highest-ranked approaches all prioritised diagnostics, directing between 70 and 90 per cent of their modeled allocation towards improving diagnostic performance.

The highest-ranked strategy allocated 90 per cent to diagnostic improvement and 10 per cent to targeted vector control. In the model, it reached the defined parasite-reservoir threshold 29 per cent faster and at 46 per cent lower cost than the current  Insecticide-treated nets (ITN)-focused practice..

The finding is not an argument for abandoning  ITNs or antimalarial medicines. Rather, it suggests a different sequence: diagnose accurately and quickly, identify where the problem is, then target vector control and treatment more rationally.

The paper cites an estimated 282 million malaria cases and 610,000 deaths globally in 2024, with children under five in sub-Saharan Africa carrying much of the burden. At the same time, emerging artemisinin partial resistance threatens the effectiveness of medicines that have formed the backbone of malaria treatment for years.

What the study does and does not show

The researchers caution against interpreting the results from the mathematical modelling work as proof that reallocating malaria budgets will automatically produce the simulated outcomes.

The study uses mathematical modelling and published data rather than human participants. Its parasite-reservoir threshold is also a modelling benchmark and should not be confused with the World Health Organisation’s definition of malaria elimination.

Further validation against country-level surveillance data will therefore be necessary. The researchers also identify explicit modeling of WHO-recommended antimalarial drug-diversification approaches as an area for future work.

For decades, the fight has concentrated heavily on stopping mosquitoes from transmitting malaria and ensuring effective medicines are available when people become infected.

This study adds another front. Find the infection. Find it early. And above all, do not let malaria hide in a false negative.

Article written by Stephen Wakhu

Adapted from www.strathmore.edu on 8th September 2026 at 18:37 hrs: https://strathmore.edu/news-articles/study-puts-sensitive-diagnosis-at-the-heart-of-the-fight-against-malaria/